Utility of testing for apraxia and associated features in dementia.
Utility of testing for apraxia and associated features in dementia.
复制标题
DOI:
10.1136/jnnp-2015-312945
复制
发表时间:
2016-11
期刊:
影响因子:
--
通讯作者:
Butler CR
中科院分区:
文献类型:
--
作者:
Ahmed S;Baker I;Thompson S;Husain M;Butler CR
Existing literature suggests that the presence or absence of apraxia and associated parietal deficits may be clinically relevant in differential diagnosis of dementia syndromes. This study investigated the profile of these features in Alzheimer's disease (AD) and frontotemporal dementia (FTD) spectrum disorders, at first presentation. Retrospective case note analysis was undertaken in 111 patients who presented to the Oxford Cognitive Disorders Clinic, Oxford, UK, including 29 amnestic AD, 12 posterior cortical atrophy (PCA), 12 logopenic primary progressive aphasia (lvPPA), 20 behavioural variant FTD (bvFTD), 7 non-fluent variant PPA (nfvPPA), 6 semantic variant PPA (svPPA) and 25 patients with subjective cognitive impairment (SCI). The clinical features of interest were: limb apraxia, apraxia of speech (AOS), and left parietal symptoms of dyslexia, dysgraphia, and dyscalculia. The prevalence of limb apraxia was highest in PCA, amnestic AD, lvPPA and nfvPPA. AOS was only observed in nfvPPA. Associated parietal features were more prevalent in AD spectrum than FTD spectrum disorders. Group comparisons between key differential diagnostic challenges showed that lvPPA and nfvPPA could be significantly differentiated on the presence of left parietal features and AOS, and amnestic AD could be differentiated from bvFTD, svPPA and SCI by limb apraxia. Regression analysis showed that limb apraxia could successfully differentiate between AD and FTLD spectrum disorders with 83% accuracy. Disease-specific profiles of limb apraxia and associated deficits can be observed. FTD and AD spectrum disorders can be difficult to differentiate due to overlapping cognitive symptoms, and measures of apraxia, in particular, appear to be a promising discriminator.
登录
查看更多内容
DOI:
10.1016/j.jalz.2011.03.005
发表时间:
2011-05
期刊:
Alzheimer's & dementia : the journal of the Alzheimer's Association
影响因子:
--
作者:
McKhann GM;Knopman DS;Chertkow H;Hyman BT;Jack CR Jr;Kawas CH;Klunk WE;Koroshetz WJ;Manly JJ;Mayeux R;Mohs RC;Morris JC;Rossor MN;Scheltens P;Carrillo MC;Thies B;Weintraub S;Phelps CH
通讯作者:
Phelps CH
影响因子:
6
作者:
Adeli A;Whitwell JL;Duffy JR;Strand EA;Josephs KA
通讯作者:
Josephs KA
影响因子:
14.5
作者:
Kas, Aurelie;de Souza, Leonardo Cruz;Sarazin, Marie
通讯作者:
Sarazin, Marie
影响因子:
14.5
作者:
Libon, David J.;Rascovsky, Katya;Grossman, Murray
通讯作者:
Grossman, Murray
影响因子:
9.9
作者:
McMonagle, P;Deering, F;Kertesz, A
通讯作者:
Kertesz, A